β-cell senescence in type 2 diabetes
Open Access
- 25 November 2019
- journal article
- editorial
- Published by Impact Journals, LLC in Aging
- Vol. 11 (22) , 9967-9968
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Acceleration of β Cell Aging Determines Diabetes and Senolysis Improves Disease OutcomesCell Metabolism, 2019
- L1 drives IFN in senescent cells and promotes age-associated inflammationNature, 2019
- The Clinical Potential of Senolytic DrugsJournal of the American Geriatrics Society, 2017
- β Cell Aging Markers Have Heterogeneous Distribution and Are Induced by Insulin ResistanceCell Metabolism, 2017
- The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor SuppressionAnnual Review of Pathology: Mechanisms of Disease, 2010
- Cellular senescence: when bad things happen to good cellsNature Reviews Molecular Cell Biology, 2007
- Interleukin-1–Receptor Antagonist in Type 2 Diabetes MellitusNew England Journal of Medicine, 2007
- Five Stages of Evolving Beta-Cell Dysfunction During Progression to DiabetesDiabetes, 2004